In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine

Tse Wen Chang, Esteban Celis, Richard W. Miller, Vincent R. Zurawski, Patrick C. Kung

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Lymphocytes isolated from recipients of hepatitis B vaccine were studied for their immune response to HBsAg in vitro. Peripheral blood mononuclear cells (PBMs) from 70 to 80% of 40 vaccinees yielded proliferative indices larger than 2 after 5 to 7 days incubation with HBsAg. This in vitro proliferative response could be augmented by incubating the cells with HBsAg and supernatants of activated T cells for 2 weeks or longer. After 7 to 10 days, in vitro stimulation with antigen, PBMs (1 ± 106) could yield 5 to 15 HBsAg‐specific antibody‐secreting plaque‐forming cells. The antibody to HBsAg produced in vitro was greatly increased in cultures that contained antigen‐specific B cells enriched by panning with HBsAg‐coated plates and a T cell growth factor‐dependent, HBsAg‐specific autologous T cell line. The results indicate that HBsAg‐specific B and T cells are present, although at low frequencies, in the circulation of hepatitis B vaccinees.

Original languageEnglish (US)
Pages (from-to)824-829
Number of pages6
JournalHepatology
Volume4
Issue number5
DOIs
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Hepatitis B Vaccines
Hepatitis B Surface Antigens
Lymphocytes
T-Lymphocytes
B-Lymphocytes
Hepatitis B
Blood Cells
Antigens
Cell Line
In Vitro Techniques
Antibodies
Growth
phytobacteriomycin

ASJC Scopus subject areas

  • Hepatology

Cite this

In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine. / Chang, Tse Wen; Celis, Esteban; Miller, Richard W.; Zurawski, Vincent R.; Kung, Patrick C.

In: Hepatology, Vol. 4, No. 5, 01.01.1984, p. 824-829.

Research output: Contribution to journalArticle

Chang, Tse Wen ; Celis, Esteban ; Miller, Richard W. ; Zurawski, Vincent R. ; Kung, Patrick C. / In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine. In: Hepatology. 1984 ; Vol. 4, No. 5. pp. 824-829.
@article{f452c61e9a79459d9f15b0c393544322,
title = "In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine",
abstract = "Lymphocytes isolated from recipients of hepatitis B vaccine were studied for their immune response to HBsAg in vitro. Peripheral blood mononuclear cells (PBMs) from 70 to 80{\%} of 40 vaccinees yielded proliferative indices larger than 2 after 5 to 7 days incubation with HBsAg. This in vitro proliferative response could be augmented by incubating the cells with HBsAg and supernatants of activated T cells for 2 weeks or longer. After 7 to 10 days, in vitro stimulation with antigen, PBMs (1 ± 106) could yield 5 to 15 HBsAg‐specific antibody‐secreting plaque‐forming cells. The antibody to HBsAg produced in vitro was greatly increased in cultures that contained antigen‐specific B cells enriched by panning with HBsAg‐coated plates and a T cell growth factor‐dependent, HBsAg‐specific autologous T cell line. The results indicate that HBsAg‐specific B and T cells are present, although at low frequencies, in the circulation of hepatitis B vaccinees.",
author = "Chang, {Tse Wen} and Esteban Celis and Miller, {Richard W.} and Zurawski, {Vincent R.} and Kung, {Patrick C.}",
year = "1984",
month = "1",
day = "1",
doi = "10.1002/hep.1840040504",
language = "English (US)",
volume = "4",
pages = "824--829",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine

AU - Chang, Tse Wen

AU - Celis, Esteban

AU - Miller, Richard W.

AU - Zurawski, Vincent R.

AU - Kung, Patrick C.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Lymphocytes isolated from recipients of hepatitis B vaccine were studied for their immune response to HBsAg in vitro. Peripheral blood mononuclear cells (PBMs) from 70 to 80% of 40 vaccinees yielded proliferative indices larger than 2 after 5 to 7 days incubation with HBsAg. This in vitro proliferative response could be augmented by incubating the cells with HBsAg and supernatants of activated T cells for 2 weeks or longer. After 7 to 10 days, in vitro stimulation with antigen, PBMs (1 ± 106) could yield 5 to 15 HBsAg‐specific antibody‐secreting plaque‐forming cells. The antibody to HBsAg produced in vitro was greatly increased in cultures that contained antigen‐specific B cells enriched by panning with HBsAg‐coated plates and a T cell growth factor‐dependent, HBsAg‐specific autologous T cell line. The results indicate that HBsAg‐specific B and T cells are present, although at low frequencies, in the circulation of hepatitis B vaccinees.

AB - Lymphocytes isolated from recipients of hepatitis B vaccine were studied for their immune response to HBsAg in vitro. Peripheral blood mononuclear cells (PBMs) from 70 to 80% of 40 vaccinees yielded proliferative indices larger than 2 after 5 to 7 days incubation with HBsAg. This in vitro proliferative response could be augmented by incubating the cells with HBsAg and supernatants of activated T cells for 2 weeks or longer. After 7 to 10 days, in vitro stimulation with antigen, PBMs (1 ± 106) could yield 5 to 15 HBsAg‐specific antibody‐secreting plaque‐forming cells. The antibody to HBsAg produced in vitro was greatly increased in cultures that contained antigen‐specific B cells enriched by panning with HBsAg‐coated plates and a T cell growth factor‐dependent, HBsAg‐specific autologous T cell line. The results indicate that HBsAg‐specific B and T cells are present, although at low frequencies, in the circulation of hepatitis B vaccinees.

UR - http://www.scopus.com/inward/record.url?scp=0021157484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021157484&partnerID=8YFLogxK

U2 - 10.1002/hep.1840040504

DO - 10.1002/hep.1840040504

M3 - Article

VL - 4

SP - 824

EP - 829

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -